Índice do Artigo
Conteúdo do Artigo
· 3 min read

Does the expansion of digital channels change the competition for availability in pharmacies?

The entry of digital channels into pharmacy sales expands reach, but raises the risk of hidden stockouts and demands recurring inventory visibility.


With the multiplication of digital storefronts focused on the pharmaceutical retail, the daily challenge for sales teams is no longer just placing the product in the catalog, but ensuring it actually reaches the buyer's hands. The feeling of expanded capillarity masks a silent operational problem.

The health and wellness shopping journey has gained new touchpoints, decentralizing sales and fragmenting the signals reaching the pharmaceutical industry. It is entirely understandable that sales managers see in these environments an immediate opportunity for revenue expansion and audience reach.

However, there is a hidden premise in this strategy: believing that being listed in multiple virtual locations equates to having the product available and delivered consistently. Confusing digital presence with actual availability is the shortest path to losing sales.

The mechanism of hidden stockout

When the portfolio is distributed across physical chains and digital platforms without a unified reading, the stockout ceases to be an obvious event and becomes invisible to the manufacturer's eyes. While the consolidated central inventory indicates that sell-in volumes have been met, the product may vanish from virtual or physical shelves in strategic regions.

The practical result is well known: the consumer searches for the medication, finds the item unavailable, and migrates to the competition. The field team only notices the loss weeks later, when consolidated sales reports show the contraction, without pointing to the exact cause.

Some analysts attribute this fluctuation exclusively to price variation or seasonal preference for competing brands. Although consumer behavior plays a role, ignoring the availability factor prevents the company from taking immediate corrective action.

To shield the portfolio against stockouts in pharmacies, the manufacturer needs to cross-reference fragmented data and obtain a recurring reading by point of sale and chain. It is precisely to solve this front that Dinn Stock, currently available, operates by prioritizing correction actions by SKU, chain, city, state, or point of sale, POS.

Visibility must precede commercial damage. Without separating the digital inventory from the storefront and the effective availability at the delivery point, the digital expansion strategy ends up funding the competitor's growth.

Transform data into strategic decisions

Dinn centralizes market intelligence for the pharmaceutical industry — real-time POS monitoring, out-of-stock tracking, and sell-out data.

Request a demo
Back to Blog